BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 15915152)

  • 21. Detecting drug targets with minimum side effects in metabolic networks.
    Li Z; Wang RS; Zhang XS; Chen L
    IET Syst Biol; 2009 Nov; 3(6):523-33. PubMed ID: 19947778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomics and systems biology in malaria drug discovery.
    Dharia NV; Chatterjee A; Winzeler EA
    Curr Opin Investig Drugs; 2010 Feb; 11(2):131-8. PubMed ID: 20112162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systems biology in drug safety and metabolism: integration of microarray, real-time PCR and enzyme approaches.
    Yengi LG
    Pharmacogenomics; 2005 Mar; 6(2):185-92. PubMed ID: 15882137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemical biology and drug design: three-dimensional, dynamic, and mechanistic nature of two multidisciplinary fields.
    Sawyer TK
    Chem Biol Drug Des; 2006 Mar; 67(3):196-200. PubMed ID: 16611212
    [No Abstract]   [Full Text] [Related]  

  • 25. The rise and rise of drug delivery.
    Rosen H; Abribat T
    Nat Rev Drug Discov; 2005 May; 4(5):381-5. PubMed ID: 15864267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysing microarray data in drug discovery using systems biology.
    Chen BS; Li CW
    Expert Opin Drug Discov; 2007 May; 2(5):755-68. PubMed ID: 23488963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ligand-based vascular targeting of disease.
    Rybak JN; Trachsel E; Scheuermann J; Neri D
    ChemMedChem; 2007 Jan; 2(1):22-40. PubMed ID: 17154429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can cell systems biology rescue drug discovery?
    Butcher EC
    Ernst Schering Res Found Workshop; 2007; (61):153-72. PubMed ID: 17249501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From targets to leads: the importance of advanced data analysis for decision support in drug discovery.
    Fischer HP; Heyse S
    Curr Opin Drug Discov Devel; 2005 May; 8(3):334-46. PubMed ID: 15892249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pivotal role of drug metabolism and pharmacokinetics in the discovery and development of new medicines.
    Alavijeh MS; Palmer AM
    IDrugs; 2004 Aug; 7(8):755-63. PubMed ID: 15334309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Society for Biomolecular Sciences--15th Annual Conference. Bioassay and technology innovation: 15 years of shaping drug discovery. 26-30 April 2009, Lille, France.
    Napper AD
    IDrugs; 2009 Jun; 12(6):363-5. PubMed ID: 19517316
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug-target residence time and its implications for lead optimization.
    Copeland RA; Pompliano DL; Meek TD
    Nat Rev Drug Discov; 2006 Sep; 5(9):730-9. PubMed ID: 16888652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-throughput electronic biology: mining information for drug discovery.
    Loging W; Harland L; Williams-Jones B
    Nat Rev Drug Discov; 2007 Mar; 6(3):220-30. PubMed ID: 17330071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global metabolic profiling and its role in systems biology to advance personalized medicine in the 21st century.
    Schnackenberg LK
    Expert Rev Mol Diagn; 2007 May; 7(3):247-59. PubMed ID: 17489732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccine manufacturing: challenges and solutions.
    Ulmer JB; Valley U; Rappuoli R
    Nat Biotechnol; 2006 Nov; 24(11):1377-83. PubMed ID: 17093488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular targets and cancer therapeutics.
    Westwell AD
    Drug Discov Today; 2004 Dec; 9(24):1042-4. PubMed ID: 15582792
    [No Abstract]   [Full Text] [Related]  

  • 37. High-throughput screening, metabolomics and drug discovery.
    Harrigan GG; Yates LA
    IDrugs; 2006 Mar; 9(3):188-92. PubMed ID: 16523384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression profiling in drug discovery and development.
    Stratowa C; Wilgenbus KK
    Curr Opin Mol Ther; 1999 Dec; 1(6):671-9. PubMed ID: 19629863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomics and systems biology: application in drug discovery and development.
    Chakravarti B; Mallik B; Chakravarti DN
    Methods Mol Biol; 2010; 662():3-28. PubMed ID: 20824464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Designing transient binding drugs: a new concept for drug discovery.
    Ohlson S
    Drug Discov Today; 2008 May; 13(9-10):433-9. PubMed ID: 18468561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.